252 related articles for article (PubMed ID: 9152947)
1. Preferential histiotypic expression of CD44-isoforms in human lung cancer.
Wimmel A; Schilli M; Kaiser U; Havemann K; Ramaswamy A; Branscheid D; Kogan E; Schuermann M
Lung Cancer; 1997 Mar; 16(2-3):151-72. PubMed ID: 9152947
[TBL] [Abstract][Full Text] [Related]
2. Isoform expression of CD44 adhesion molecules, Bcl-2, p53 and Ki-67 proteins in lung cancer.
Mizera-Nyczak E; Dyszkiewicz W; Heider KH; Zeromski J
Tumour Biol; 2001; 22(1):45-53. PubMed ID: 11054026
[TBL] [Abstract][Full Text] [Related]
3. Expression of CD44 splicing isoforms in lung cancers: dominant expression of CD44v8-10 in non-small cell lung carcinomas.
Sasaki JI; Tanabe KK; Takahashi K; Okamoto I; Fujimoto H; Matsumoto M; Suga M; Ando M; Saya H
Int J Oncol; 1998 Mar; 12(3):525-33. PubMed ID: 9472088
[TBL] [Abstract][Full Text] [Related]
4. [Expression of standard and variant CD44 in human lung cancer].
Zhao H; Fang J; Du G
Zhonghua Jie He He Hu Xi Za Zhi; 1998 Sep; 21(9):541-3. PubMed ID: 11360506
[TBL] [Abstract][Full Text] [Related]
5. CD44 splicing pattern is associated with disease progression in pulmonary adenocarcinoma.
Lee LN; Kuo SH; Lee YC; Chang YL; Chang HC; Jan IS; Yang PC
J Formos Med Assoc; 2005 Aug; 104(8):541-8. PubMed ID: 16193174
[TBL] [Abstract][Full Text] [Related]
6. Expression of alternatively spliced forms of the CD44 extracellular-matrix receptor on human lung carcinomas.
Jackson DG; Schenker T; Waibel R; Bell JI; Stahel RA
Int J Cancer Suppl; 1994; 8():110-5. PubMed ID: 7515025
[TBL] [Abstract][Full Text] [Related]
7. The expression of the CD44 variant exon 6 is associated with lymph node metastasis in non-small cell lung cancer.
Miyoshi T; Kondo K; Hino N; Uyama T; Monden Y
Clin Cancer Res; 1997 Aug; 3(8):1289-97. PubMed ID: 9815811
[TBL] [Abstract][Full Text] [Related]
8. High frequency expressions of CD44 standard and variant forms in non-small cell lung cancers, but not in small cell lung cancers.
Kondo K; Miyoshi T; Hino N; Shimizu E; Masuda N; Takada M; Uyama T; Monden Y
J Surg Oncol; 1998 Nov; 69(3):128-36. PubMed ID: 9846498
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of CD44 variant transcripts in rat transplantable thyroid carcinoma lines demonstrating lung metastasis.
Kitahori Y; Cho M; Konishi N; Ohshima M; Matsui E; Ohnishi T; Imai S; Hiasa Y
Int J Oncol; 1998 Sep; 13(3):505-11. PubMed ID: 9683785
[TBL] [Abstract][Full Text] [Related]
10. Expression of human CD44v6 in non-small-cell lung cancer.
Carbognani P; Spaggiari L; Romani A; Solli P; Corradi A; Cantoni AM; Petronini PG; Borghetti AF; Rusca M; Bobbio P
Eur Surg Res; 1998; 30(6):403-8. PubMed ID: 9838232
[TBL] [Abstract][Full Text] [Related]
11. CD44 and its v6 spliced variant in lung carcinomas: relation to NCAM, CEA, EMA and UP1 and prognostic significance.
Nguyen VN; Mirejovský T; Melinová L; Mandys V
Neoplasma; 2000; 47(6):400-8. PubMed ID: 11263866
[TBL] [Abstract][Full Text] [Related]
12. The expression of variant exon v7-v8 CD44 antigen in relation to lymphatic metastasis of human breast cancer.
Kinoshita J; Haga S; Shimizu T; Imamura H; Watanabe O; Kajiwara T
Breast Cancer Res Treat; 1999 Jan; 53(2):177-83. PubMed ID: 10326795
[TBL] [Abstract][Full Text] [Related]
13. Neutral endopeptidase: variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux.
Cohen AJ; Bunn PA; Franklin W; Magill-Solc C; Hartmann C; Helfrich B; Gilman L; Folkvord J; Helm K; Miller YE
Cancer Res; 1996 Feb; 56(4):831-9. PubMed ID: 8631021
[TBL] [Abstract][Full Text] [Related]
14. Receptor for hyaluronic acid-mediated motility (RHAMM, CD168) expression is prognostically important in both nodal negative and nodal positive large cell lung cancer.
Augustin F; Fiegl M; Schmid T; Pomme G; Sterlacci W; Tzankov A
J Clin Pathol; 2015 May; 68(5):368-73. PubMed ID: 25731190
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of CD44 splice variants in malignant and benign pleural effusions.
Tojo N; Inase N; Ichioka M; Miyazato I; Nara N
Tohoku J Exp Med; 1996 Aug; 179(4):273-9. PubMed ID: 8944429
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of cells with cancer stem cell properties in human primary lung cancer cell lines.
Wang P; Gao Q; Suo Z; Munthe E; Solberg S; Ma L; Wang M; Westerdaal NA; Kvalheim G; Gaudernack G
PLoS One; 2013; 8(3):e57020. PubMed ID: 23469181
[TBL] [Abstract][Full Text] [Related]
17. Differential expression and pathological significance of autocrine motility factor/glucose-6-phosphate isomerase expression in human lung carcinomas.
Dobashi Y; Watanabe H; Sato Y; Hirashima S; Yanagawa T; Matsubara H; Ooi A
J Pathol; 2006 Dec; 210(4):431-40. PubMed ID: 17029220
[TBL] [Abstract][Full Text] [Related]
18. Expression of CD44 splice variants in human skin and epidermal tumours.
Seiter S; Tilgen W; Herrmann K; Schadendorf D; Patzelt E; Möller P; Zöller M
Virchows Arch; 1996 Jun; 428(3):141-9. PubMed ID: 8688968
[TBL] [Abstract][Full Text] [Related]
19. Altered expression of CD44 isoforms in squamous-cell carcinomas and cell lines derived from them.
Hudson DL; Speight PM; Watt FM
Int J Cancer; 1996 May; 66(4):457-63. PubMed ID: 8635860
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of the human metastasis adhesion molecule CD44V in normal and carcinomatous stomach mucosa of Chinese subjects.
Harn HJ; Ho LI; Chang JY; Wu CW; Jiang SY; Lee HS; Lee WH
Cancer; 1995 Mar; 75(5):1065-71. PubMed ID: 7531611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
